ADVANCEMENTS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL PROGRAMS

Recombinant human serum albumin (OsrHSA) has emerged as a major innovation in the field of biopharmaceuticals, presenting promising progress throughout several healthcare and industrial programs. With its structural similarity to Obviously derived human serum albumin, OsrHSA delivers a safer, far more trustworthy different for therapeutic use, part